WHO Ebola vaccine funding review raises questions over $60M platform expansion tied to COVID-era systems
A WHO Ebola vaccine funding review has sparked debate over $60 million in expanded vaccine development using COVID-era platforms. Critics question transparency, while officials emphasize rapid outbreak readiness.